Related by context. All words. (Click for frequent words.) 76 preoperative PSA 72 APACHE II 71 pT3 70 extracapsular extension 70 #.#ng/ml 69 MMSE score 68 BMI z 68 -#.# ± [002] 68 Ishak fibrosis score 67 p = .# [002] 67 WOMAC pain 67 NIHSS 67 biochemical recurrence 66 PANSS total 66 PSA nadir 66 SUVmax 66 multivariable analysis 66 histologic subtype 66 % CI #.#-#.# [007] 66 CHADS2 65 NYHA functional class 65 SGRQ 65 UPDRS motor 65 postoperative complication 65 ECOG PS 65 pT2 65 pCR 65 T1c 65 biochemical relapse 64 radical prostatectomy RP 64 LS BMD 64 % Confidence Interval 64 Rating Scale MADRS 64 CIN2 + 64 DAS# CRP 64 intima media thickness 64 intact parathyroid hormone 64 mL/min/#.# m 2 64 histologically proven 64 advanced adenoma 64 PANSS 64 univariate analysis 64 Y BOCS 64 HDRS 64 HOMA IR 64 confidence intervals CIs 64 FDG uptake 64 interrater reliability 64 Montgomery Åsberg Depression 64 hip BMD 64 interobserver reliability 63 % CI #.#-#.# [003] 63 ADAS cog 63 locoregional recurrence 63 #ng/ml 63 specific antigen PSA 63 Index CDAI 63 underwent resection 63 CI -#.# 63 χ 63 femoral neck BMD 63 coronary stenosis 63 LV ejection fraction 63 histological subtype 63 subscore 63 multivariable adjusted 63 serum PSA 63 endometrial thickness 63 highest tertile 63 advanced adenomas 63 Global Impression CGI 63 T1a 63 leukocyte count 63 plasma homocysteine 63 p = #.# [003] 63 IBDQ 63 QRS duration 63 histologic 63 Preoperatively 63 lymphovascular invasion 62 multivariate analyzes 62 baseline PASI 62 colorectal adenoma 62 HER2 expression 62 thyroglobulin 62 preoperatively 62 pretest probability 62 HADS 62 P = .# 62 Brief Psychiatric 62 confidence interval #.#-#.# 62 correlation coefficients 62 #Gy 62 mRS 62 NIH CPSI 62 CR nPR 62 CORE OM 62 % CI #.#-#.# [001] 62 PSADT 62 â ‰ ¥ 62 Operative mortality 62 seminal vesicle invasion 62 gadolinium enhanced 62 intraobserver 62 lowest tertile 62 liver histology 62 DLQI 62 LV dysfunction 62 posttreatment 62 grade squamous intraepithelial 62 EDSS score 62 lymph node metastasis 62 P ≤ 61 undetectable HBV DNA 61 nonobese 61 nonmetastatic 61 Kellgren Lawrence 61 MMSE scores 61 β = 61 Pearson correlation coefficient 61 lymphocytosis 61 lactate dehydrogenase 61 lymph node involvement 61 isoprostane 61 HbA 1c levels 61 nondiabetic patients 61 BPH symptom 61 HGPIN 61 PCA3 scores 61 receiving Vectibix monotherapy 61 fractional anisotropy 61 ALT elevation 61 MetS 61 univariate analyzes 61 univariate 61 serum ferritin 61 prostatic adenocarcinoma 61 interobserver 61 PSQI 61 radiotherapy RT 61 prognostic variables 61 urothelial carcinoma 61 Hazard Ratio HR 61 Scale EDSS 61 tertiles 61 Kruskal Wallis test 61 % CI #.#-#.# [008] 61 Immunohistochemical staining 61 prostate cancer CaP 61 Crohn Disease Activity 61 carotid stenosis 61 ß = 61 grade cervical intraepithelial 61 Histologic 61 NNT = 61 lumbar spine BMD 61 graft occlusion 61 DAS# [002] 61 elevated ALT 61 definite stent thrombosis 61 urine albumin 60 #OHD 60 carotid artery intima media 60 advanced neoplasia 60 wedge resection 60 PCa 60 F FDG PET 60 Breslow thickness 60 regression coefficients 60 CIN3 60 hormone receptor negative 60 Glasgow Coma Scale 60 CNS LS 60 ADAS Cog 60 haematologic 60 CCyR 60 Rating Scale BPRS 60 tPSA 60 Health Assessment Questionnaire 60 hepatocellular carcinomas 60 ejection fractions 60 unpaired t 60 DAS# remission 60 underwent surgical resection 60 troponin T 60 cytologic 60 T3 T4 60 chi squared 60 posttest 60 Visual Analogue Scale VAS 60 IRLS score 60 invasive carcinomas 60 antibody titer 60 QIDS SR 60 MADRS 60 ADCS CGIC 60 histopathologic 60 pmol L 60 erythrocyte sedimentation rate 60 carotid IMT 60 completely resected 60 gadolinium enhancing 60 Severity Index PASI 60 response pCR 60 Montgomery Asberg Depression 60 serum prostate 60 % CI #.#-#.# [005] 60 undetectable PSA 60 Coronary artery calcium 60 HbA1C levels 60 distant metastasis 60 Pearson correlation coefficients 60 ‰ ¥ 60 HbA 1c 60 multivariate Cox 60 subscores 60 BPRS 60 Charlson comorbidity index 60 EQ 5D 60 x ULN 60 lymphadenectomy 60 serum urate levels 60 tertile 60 echocardiographic parameters 60 neoplasias 60 serum TSH 60 YMRS 60 plain radiographs 60 receiving VICTRELIS 60 DEXA scans 60 interobserver agreement 59 MADRS score 59 clinicopathological features 59 diabetes mellitus DM 59 μg liter 59 visceral metastases 59 cervical intraepithelial neoplasia 59 NMIBC 59 vitreous haze 59 VATS lobectomy 59 hemoglobin A1c levels 59 urinary N telopeptide 59 ug ml 59 Interrater reliability 59 Visual Analog 59 symptomatic DVT 59 #.#,#.# [002] 59 immunostaining 59 statistical significance p 59 ischemic lesions 59 % CI #.#-#.# [006] 59 radical nephrectomy 59 sonographically guided 59 nonparametric 59 intrahepatic 59 transvaginal sonography 59 creatine kinase MB 59 endometrioid 59 affective psychosis 59 T2 lesions 59 residual stenosis 59 obstructive coronary artery 59 adjunctive placebo 59 morphometric vertebral fractures 59 systolic dysfunction 59 elevated LDH 59 Alzheimer Disease Assessment 59 clinically meaningful improvement 59 highest quintile 59 State Exam MMSE 59 CI #.#-#.# [001] 59 Fibromyalgia Impact Questionnaire 59 operable breast cancer 59 p = .# [001] 59 sd = 59 baseline HbA1c 59 intraclass correlation coefficient 59 obstructive CAD 59 osteopenic 59 prostate carcinoma 59 aminotransferase levels 59 postintervention 59 invasive lobular 59 TURBT 59 DAS# scores 59 Kaplan Meier estimates 59 logistic regression analysis 59 HAQ DI 59 μmol L 59 -#.# log# 59 hydroxyvitamin D levels 59 mg/m2 dose 59 microsatellite instability 59 sUA 59 euthyroid 59 regression coefficient 59 estimated glomerular filtration 59 alanine aminotransferase 59 XIENCE V PROMUS Stent 59 Kaplan Meier 59 creatinine ratio 59 CC genotype 59 FDG PET imaging 59 histopathologic examination 59 neurodevelopmental impairment 59 hemoglobin Hb 59 ANOVA 59 APOC3 59 Injury Severity Score 59 symptomatic VTE 59 mU L 59 p ≤ 59 hemodynamically significant 59 nonfatal MI 59 odds ratios ORs 59 Lumbar spine 59 heterozygotes 59 serum IGF 59 HAMD 59 postop 59 ASCUS 59 baseline LDH 59 % CI #.#-#.# [004] 59 conditional logistic regression 59 kidney allograft 59 ultrasonographic 59 relapsed MM 59 alanine aminotransferase ALT 59 elevated transaminases 59 mmol l 59 CR CRu 58 μg dl 58 serum bilirubin 58 genotypic resistance 58 atheroma volume 58 pathologic diagnosis 58 PASI scores 58 nodal metastases 58 HBeAg 58 glycosylated hemoglobin HbA1c 58 normal karyotype 58 stage IIIb IV 58 invasive ductal 58 tHcy 58 CHADS 58 treated nonoperatively 58 REYATAZ r arm 58 PERMP 58 aspartate aminotransferase 58 postoperative chemotherapy 58 Index CDAI score 58 neuropathy sensory 58 Pred Forte 58 r2 = 58 incomplete revascularization 58 histologically confirmed 58 multivariable Cox 58 serum cortisol 58 Pain Rating Scale 58 Postoperatively 58 SLNB 58 contralateral breast 58 colorectal polyp 58 Wilcoxon rank sum 58 esophageal carcinoma 58 extracolonic findings 58 artery stenosis 58 clinicopathologic 58 endoscopic remission 58 lymphocyte count 58 clinicopathological 58 mucinous 58 metachronous 58 neutrophil counts 58 prognostic significance 58 LDL HDL 58 CaP 58 -#.# ± [001] 58 CHADS 2 58 nonalcoholic steatohepatitis NASH 58 Univariate analysis 58 KOOS 58 hematopoietic cancers 58 MBq 58 fasting plasma 58 sensitivity specificity 58 renal cell carcinomas 58 System IPSS 58 albumin excretion 58 pelvic lymphadenectomy 58 non squamous histology 58 Common Toxicity Criteria 58 point Likert scale 58 Neuropsychiatric Inventory 58 HBeAg negative patients 58 polyp recurrence 58 FDG-PET/CT 58 axillary lymph node 58 Cronbach alpha 58 lopinavir r arm 58 attain statistical significance 58 UPDRS 58 mU liter 58 left ventricular diastolic 58 TT genotype 58 preoperative chemotherapy 58 IL#B 58 subscale scores 58 axillary node 58 Disease Activity 58 WOMAC 58 macroalbuminuria 58 NIHSS score 58 Histological 58 preoperative diagnosis 58 hip resurfacing arthroplasty 58 gastric adenocarcinoma 58 CLL SLL 58 glomerular filtration 58 BPH Symptom Score 58 carotid artery thickness 58 Flu Cy 58 noncardiac 58 p = NS 58 prospectively defined 58 prognostic indicators 58 euthymic patients 58 UGT#A# * 58 mCi 58 adenoma recurrence 58 nonfasting triglyceride levels 58 underwent coronary angiography 58 Stroke Scale NIHSS 58 postoperative radiographs 58 apolipoprotein B 58 timepoints 58 comorbidity 58 baseline FEV 58 #mmHg [001] 58 pathologic 58 cardiac perfusion 58 secondary efficacy endpoint 58 tumor histology 58 CD# expression [002] 58 bladder carcinoma 58 perioperative mortality 58 echogenicity 58 interquartile range 58 hydronephrosis 58 Kaplan Meier analysis 58 CI #.#-#.# [002] 58 platelet reactivity 58 liver metastasis 58 histopathological 58 progesterone receptor negative 58 logistic regression model 58 undergone radical prostatectomy 58 nodal metastasis 58 = #.#-#.# 58 TKAs 58 pg ml 58 urine cytology 58 undergoing coronary angiography 58 mm Hg diastolic 57 mmHg diastolic 57 HER2 amplification 57 mg BID dose 57 spine BMD 57 perioperative complications 57 elevated troponin 57 EBRT 57 rho = 57 nasal symptom 57 ErbB2 positive 57 gadolinium enhancing lesions 57 carcinoembryonic antigen 57 International Prognostic Scoring 57 logistic regression analyzes 57 glycated hemoglobin levels 57 statistically significant p = 57 postinjury 57 fasting insulin 57 T2 lesion volume 57 4mg/kg 57 Expanded Disability Status 57 PREZISTA r arm 57 periprocedural 57 Plasma concentrations 57 pulsatility index 57 epididymal 57 breast carcinomas 57 postprocedure 57 amnestic MCI 57 lymph node metastases 57 symptomatic intracerebral hemorrhage 57 acute cholecystitis 57 TC HDL 57 Fontan procedure 57 prospectively evaluated 57 bioavailable testosterone 57 diastolic pressures 57 adiponectin concentrations 57 osteosarcomas 57 prespecified secondary 57 Subgroup analysis 57 intravesical therapy 57 TMPRSS2 ERG 57 thyrotropin levels 57 hemoglobin A1c HbA1c 57 Apgar scores 57 parenchymal 57 serum aminotransferase levels 57 hematological relapse 57 serum ALT 57 IPSS 57 IRLS 57 posttransplant 57 bivariate analyzes 57 Prognostic significance 57 Hb A1C 57 diastolic blood pressures 57 binary logistic regression 57 μg d 57 laboratory abnormalities 57 collagenous colitis 57 postoperative mortality 57 revascularization procedures 57 Glomerular filtration rate 57 p = #.# [002] 57 SCr 57 methotrexate monotherapy 57 autonomic dysfunction 57 Endothelial function 57 urothelial 57 proband 57 debulking surgery 57 coronary calcium 57 Psoriasis Area 57 HSCT 57 atypical hyperplasia 57 #q# deletion syndrome 57 sustained virological response 57 glycosylated hemoglobin levels 57 bivariate analysis 57 left ventricular LV 57 cisplatin vinorelbine 57 T2 weighted MRI 57 axillary lymph nodes 57 State Examination MMSE 57 confidence interval CI 57 NSTE ACS 57 glomerular filtration rate 57 CRp 57 visceral adiposity 57 response CCyR 57 ± SD 57 LVEF 57 oncologic outcomes 57 Folfox 57 fructosamine 57 lactate dehydrogenase LDH 57 nmol L. 57 Multivariate analysis 57 umbilical artery 57 prespecified 57 Leydig cell 57 transabdominal 57 immunohistochemical staining 57 nmol L 57 Ejection Fraction 57 Recurrence Score 57 cranial irradiation 57 sulcal 57 binary restenosis 57 elevated creatinine 57 adnexal mass 57 Secondary endpoints included 57 tumor recurrence 57 homozygotes 57 recurrent DVT 57 aortic regurgitation 57 OGTT 57 CD4 CD8 57 KRAS mutations occur 57 resected 57 severe NCI CTC 57 HRQL 57 TIMP 57 mammographic density 57 papillary thyroid carcinoma 57 histopathologic findings 57 μg dL 57 cTnI 57 de novo AML 57 ipsilateral breast 57 hepatic fibrosis 57 familial aggregation 57 spirometric 57 angiographically 57 MACCE 57 extracranial 57 CDAI score 57 antiretroviral naïve 57 TRUS 57 BMI ≥ 57 lateral radiograph 57 dacarbazine DTIC 57 malignant nodules 57 serum estradiol 57 serum PTH 57 multivariable analyzes 57 transferrin saturation 57 Papillary 57 severe neutropenia 57 SLN biopsy 56 depressive symptom 56 bivariate 56 methacholine challenge 56 graft dysfunction 56 nonobese patients 56 HBeAg negative 56 nephrectomy 56 Visual acuity 56 #.#mmol L [002] 56 #.#-#.# [011] 56 serum testosterone 56 umol L 56 mineral density BMD 56 lobular carcinomas 56 hamartomas 56 distant metastases 56 overt hypothyroidism 56 Ashworth Scale 56 hippocampal atrophy 56 ROC curves 56 histologic findings 56 PANSS scores 56 achieved statistical significance 56 leucopenia 56 axillary node dissection 56 mmHg p = 56 Oswestry Disability Index 56 ≥ 56 renal cysts 56 achieved ACR# 56 resectable 56 mg p = 56 neuritic 56 mean baseline A1C 56 total thyroidectomy 56 HER2 homodimer levels 56 mTSS 56 carotid intima media 56 myocardial blush 56 pmol 56 thromboembolic complications 56 primary aldosteronism 56 serum CRP 56 nonischemic 56 progression TTP 56 chemoradiation therapy 56 surgically resected 56 hsCRP levels 56 transrectal ultrasound guided 56 renal tumors 56 Scale cognitive subscale 56 treat NNT 56 -#.# mg dL [002] 56 quantitative computed tomography 56 cytokeratin 56 idiopathic PAH 56 renal pelvis 56 receiving ISENTRESS 56 moderate renal impairment 56 hyperplastic 56 thyroid carcinoma 56 hyperintensity 56 T1 T2 56 unresectable tumors 56 colorectal neoplasms 56 pmol liter 56 Status Scale EDSS 56 nmol l 56 EpCAM expression 56 HBeAg seroconversion 56 D dimer 56 abnormal cytology 56 electrocardiographic 56 del 5q 56 peritoneal carcinomatosis 56 gastric carcinoma 56 adenoma detection 56 nonsignificant difference 56 Primary endpoints 56 QTcF 56 multiple logistic regression 56 Scale PANSS 56 AUCs 56 intraclass correlation coefficients 56 mg kg Hematide 56 BRCA1 mutation carriers 56 scintigraphic 56 ALT elevations 56 remission CR 56 hepatic lesions 56 Negative Syndrome 56 ductal cancer 56 ARB telmisartan 56 resected pancreatic cancer 56 troponins 56 Radical prostatectomy 56 triiodothyronine 56 underwent CABG 56 initiating antiretroviral therapy 56 coinfected 56 aspartate aminotransferase AST 56 PaO 2 56 micrometastasis 56 nmol 56 cellularity 56 = -#.# 56 ACR Pedi 56 stage IIIA 56 gastroduodenal 56 baseline serum creatinine 56 X ULN 56 intelligence quotient IQ 56 rs# [004] 56 Ki# 56 smoldering multiple myeloma 56 allele frequencies 56 tipranavir r 56 PHQ 9 56 HAM D 56 log# copies mL 56 bronchoalveolar lavage 56 Symptom severity 56 antithymocyte globulin 56 aPTT 56 RYGB 56 Postoperative complications 56 coronary artery calcification 56 postoperative AF 56 independent prognostic marker 56 metaplasia 56 Prostate specific antigen 56 #.#/#.# mm Hg [003] 56 creatine kinase 56 N telopeptide 56 immunohistochemical analysis 56 fluorodeoxyglucose positron emission tomography 56 hematologic toxicity 56 endometrial carcinoma 56 dactylitis 56 CDAI 56 systolic function 56 microbiological eradication 56 multivariate adjusted 56 adenomatous polyps 56 neutropaenia 56 T2DM 56 serum creatinine levels 56 Circulating tumor cells 56 Symptom Checklist 56 myocardial viability 56 resectable pancreatic cancer 56 neuromotor 56 LDL particle 56 Hazard Ratio = 56 IQR 56 μg L 56 revascularizations 56 hypogonadal 56 variance ANOVA 56 malignant lesions 56 median survivals 56 urethral stricture 56 mcg albinterferon alfa 2b 56 tortuosity 56 MMSE 56 mmol liter 56 subclinical atherosclerosis 56 ipsilateral stroke 56 immunohistochemical 56 HNSCC 56 bronchioloalveolar carcinoma 56 underwent radical prostatectomy 56 AUC0 56 acetabular fractures 56 mg TID 56 5-FU/LV 56 deep venous thromboses 56 semiquantitative 56 osteoid 56 mm Hg systolic 56 intraepithelial neoplasia 56 pancreatic adenocarcinoma 56 proton MR spectroscopy 56 Preoperative 56 histological 56 fasting triglyceride levels 56 subtrochanteric 56 Complication rates 56 pulmonary dysfunction 56 mRNA expression 56 Kaplan Meier method 56 #mmHg [002] 56 certolizumab 56 dichotomized 56 stratifying patients 56 TIMP 1 55 rheumatoid factor 55 prostate cancer PCa 55 malignant neoplasm 55 mIU L 55 erection hardness 55 plasma folate 55 hepatorenal syndrome 55 histological subtypes 55 spontaneous bacterial peritonitis 55 g cm 55 multiple linear regression 55 IIIA NSCLC 55 Hgb 55 creatinine levels 55 preintervention 55 AST ALT 55 plasma adiponectin 55 interrater 55 elevated fasting glucose 55 mmol L. 55 underwent liver transplantation 55 NSTEMI 55 sonographically 55 somatic symptom 55 urodynamic 55 coronary artery calcium 55 mCRPC 55 FDG PET scans 55 left ventricular systolic 55 generalized estimating 55 Kaplan Meier curve 55 pleural fluid 55 peak VO2 55 radical cystectomy 55 smoldering myeloma 55 femoral neck 55 lesional 55 treated nonsurgically 55 g mL 55 CVD mortality 55 esophagogastroduodenoscopy 55 epithelial tumors 55 clinically localized prostate 55 prior chemotherapy regimens 55 HRCT 55 tissue oxygenation 55 radiographic findings 55 Univariate 55 serum uric acid 55 uM 55 tracer uptake 55 prognostic factors 55 Hurthle cell 55 ETDRS 55 #.#/# [005] 55 mutated K ras 55 IU ml 55 abnormal lipid 55 ACR# response 55 mIU ml 55 ovarian carcinoma 55 GH deficiency 55 CIN3 + 55 femoral neck fracture 55 T2 weighted 55 HER2 negative 55 preoperative 55 Visual Analog Scale 55 Kruskal Wallis 55 needle aspiration 55 KRAS wild 55 immunoreactivity 55 Key secondary endpoints 55 cells uL 55 EDSS 55 lobular involution 55 BEXXAR Therapeutic Regimen 55 abdominal circumference 55 estrogen receptor progesterone receptor 55 femoral shaft fracture 55 ml kg 55 varices 55 AUA Symptom Score 55 conventional angiography 55 infliximab monotherapy 55 serum magnesium 55 diameter stenosis 55 serum lipid 55 localized renal 55 SGPT 55 retest reliability 55 Doxil ® 55 serum urate 55 serum parathyroid hormone 55 WOMAC TM 55 Multivariate analyzes 55 coronary artery stenosis 55 db db mice 55 tirofiban 55 covariate 55 serum markers 55 CK MB 55 albumin excretion rate 55 NNRTI resistance 55 clinically insignificant 55 logistic regression models 55 anemia hemoglobin 55 baseline A1C 55 TNM staging 55 hemoglobin concentrations 55 recurrent VTE 55 comorbid anxiety 55 HRQoL 55 decompensated cirrhosis 55 vertebral fracture 55 myocardial necrosis 55 HbA1C 55 hypophosphatemia 55 serum concentrations 55 estrogen receptor ER 55 coronary CTA 55 VFQ 55 HIV uninfected 55 corneal curvature 55 CI #.#-#.# p = 55 sensory neuropathy 55 baseline Hb 55 PEG IFN 55 lobular carcinoma 55 luminal 55 WOMAC scores 55 complete cytogenetic 55 multivariate regression analysis 55 angiographic restenosis 55 Charlson Comorbidity Index 55 Stage IIIb 55 mineral density 55 intraabdominal 55 carotid plaque 55 helical CT 55 pg mL 55 EDSS scores 55 = .# 55 dose clopidogrel 55 rebleeding 55 complete cytogenetic response 55 nonfatal myocardial infarction 55 radiographically 55 ischemia driven 55 IELT 55 BRAF V#E 55 ng dl 55 target lesion revascularizations 55 HAM D# 55 inotropic 55 papillary RCC 55 cytologic examination 55 node metastases 55 F FLT 55 squamous 55 Likert scale 55 intraventricular hemorrhage 55 Stage IIB 55 pT 55 dosing cohort 55 Serum creatinine 55 cervical carcinoma 55 clinico pathological 55 HGD 55 ng dL 55 microgram kg 55 PSA kinetics 55 IGFBP 55 achieved PASI 55 IIb IV 55 microalbumin 55 alkaline phosphatase 55 hyperintensities 55 paresthesias 55 atrioventricular block 55 maternal serum 55 postoperative morbidity 55 adjuvant cisplatin 55 arterial thromboembolic events 55 Baseline characteristics 55 perfusion abnormalities 55 -#.# mg dL [001] 55 cystoscopic